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ABSTRACT
The availability of genotyping platforms for compre-
hensive genetic analysis of complex traits has
resulted in a plethora of studies reporting the asso-
ciation of specific single-nucleotide polymorphisms
(SNPs) with common diseases or drug responses.
However, detailed genetic analysis of these associa-
ted regions that would correlate particular polymor-
phisms to phenotypes has lagged. This is primarily
due to the lack of technologies that provide addi-
tional sequence information about genomic regions
surrounding specific SNPs, preferably in haploid
form. Enrichment methods for resequencing should
have the specificity to provide DNA linked to SNPs of
interest with sufficient quality to be used in a cost-
effective and high-throughput manner. We describe
a simple, automated method of targeting specific
sequences of genomic DNA that can directly be
used in downstream applications. The method iso-
lateshaploidchromosomal regionsflankingtargeted
SNPs by hybridizing and enzymatically elongating
oligonucleotides with biotinylated nucleotides
based on their selective binding to unique sequence
elements that differentiate one allele from any other
differing sequence. The targeted genomic region is
captured by streptavidin-coated magnetic particles
and analyzed by standard genotyping, sequencing or
microarray analysis. We applied this technology to
determine contiguous molecular haplotypes across
a ~150kb genomic region of the major histocompat-
ibility complex.
INTRODUCTION
Genetic variation between individuals has become a
focal point for genomic re-sequencing and mapping tech-
nologies, particularly since the widespread use of single
nucleotide polymorphism (SNP) markers in association
studies (1,2). Ultimately, the goal is to understand how
genetic variation aﬀects disease at an individual level, as
well as phenotypes in general. In addition to its value for
public health, the ability to eﬃciently study genetic varia-
tion in individuals and in larger populations has funda-
mental signiﬁcance for our understanding of evolution in
humans and model organisms (3,4). Recent technical
advances for determining genetic variation have focused
on the development of methods that streamline DNA ana-
lysis in parallel and automated ways as well as approaches
to address limitations of high-throughput genotyping and
statistical haplotype data interpretation (5,6).
Despite continuously improving tools for studying
genetic variation and disease, association studies based
on unrelated individuals have been less successful than
expected in uncovering genetic risk factors for common
diseases (7,8). An increasingly large number of genome-
wide association studies (9–14) report speciﬁc SNP asso-
ciations that indicate the importance of certain genomic
regions for disease susceptibility. However, the detailed
characterization of these genomic regions that would elu-
cidate the connection between genetic variation and phe-
notype can not be adequately addressed by the current
technologies. Next generation DNA sequencing methods,
thus far, lack the capability of focusing on speciﬁc DNA
fragments. Other methods that have this capability have
been developed primarily for providing haplotyping infor-
mation and are not easily applicable to the speciﬁc
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characterize these methods. Allele-speciﬁc PCR (15,16) is
generally not robust enough for amplifying stretches of
DNA at the range of about 100kb, and therefore is not
practical for long-range haplotype analysis. Clone-based
strategies (17,18) or somatic hybrid cell lines (19) are
laborious and not amenable to the degree of automation
required for population studies. Methods involving single
DNA molecule PCR ampliﬁcation (20,21) are typically
limited by the number of markers that can be studied
with just one molecule and may require special
instrumentation.
Here, we present a method for fast and eﬃcient charac-
terization of DNA segments. This method has the capabil-
ity of focusing on a particular region based on previous
knowledge of SNPs or other polymorphisms. It provides
phase information for polymorphic markers across atarget
region in a simple, automated and scalable manner.
Polymorphic phase information can be determined over
arbitrary distances by tiling. To demonstrate the method,
weselected to work with the major histocompatibility com-
plex (MHC) region for which haplotypes were already
known based on family pedigree analysis. Furthermore,
the selection of the site was inﬂuenced by the availability
of good performing TaqMan (Applied Biosystems, Foster
City, CA, USA) assays and their relative density. The selec-
tion of the MHC was also due to the signiﬁcance of this
region for the immune response and the need for mapping
haplotype variation of a region that is known for its asso-
ciation with many immune-related diseases.
Here, we describe a magnetic particle-based sample pre-
paration method that selectively puriﬁes speciﬁc,
unmodiﬁed segments of genomic DNA for the purpose
of long-range haplotype analysis. The method extends
the capabilities of existing genetic analysis systems by con-
verting the input material, diploid genomic DNA, into its
haploid components, without requiring cloning or PCR.
Any resulting typing information of this material is there-
fore also haploid. Large segments of haploid DNA can be
typed and assembled into extended molecular haplotype
blocks linked by overlapping heterozygous markers, such
as SNPs.
Extraction ofhaploid DNA based on associated SNPs
Haplotype-speciﬁc extraction exploits sequence variation
to distinguish between diﬀerent alleles or genomic regions
and selectively isolates only those regions that contain the
targeted sequence element (22). This variation can be
as small as a single base-pair diﬀerence between allelic
forms. For the purpose of molecular haplotyping, hetero-
zygous SNPs can be used to separate diploid chromosomal
segments into their maternal and paternal components
(23,24). Standard genotyping methods, performed on hap-
loid DNA, then provide deﬁnitive haplotype informa-
tion for the targeted sequence. SNP-speciﬁc extraction
consists of a four-stage process that involves identifying
a heterozygous SNP, targeting an allele with a sequence-
speciﬁc oligo, discrimination of the targeted region from
other fragments by enzymatic incorporation of biotin
tags and puriﬁcation of the targeted DNA. SNPs, as well
as other polymorphisms or unique sequences, can be
exploited to isolate only such fragments that contain this
particular sequence element.
Targeting
A SNP-speciﬁc oligonucleotide is designed with its 30-end
sequence overlapping the targeted SNP. A diploid
DNA sample is heat-denatured and the extraction
oligo is hybridized to the target sequence (Figure 1a).
For heterozygous polymorphisms, the exact sequence of
Figure 1. Extraction oligos are incubated with denatured genomic
DNA (a). Hybridization and conditional extension of the SNP-speciﬁc
oligo incorporates biotinylated nucleotides (b), which are used to selec-
tively capture the targeted allele by attachment to streptavidin-coated
magnetic microparticles (c). The targeted haploid DNA is magnetically
separated from the rest of the sample (d).
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alleles of the diploid sample. The bound extraction oligo is
enzymatically elongated with biotinylated nucleotides
(Figure 1b), which results in highly eﬃcient tagging of
only the targeted allele.
Extraction
The tagged allele is then captured, along with ﬂanking
genomic DNA, from the diploid sample by attachment to
streptavidin-coated magnetic microparticles (Figure 1c).
The haploid DNA/magnetic particle complex is washed
twice to remove nontargeted, nonspeciﬁcally bound
DNA from the surface (Figure 1d), leaving the targeted
allele of interest isolated for further analysis.
Tiling
Neighboring haploid genomic fragments are characterized
and overlapping sequences are used to determine in-phase
sequences. This forms the basis for extended molecular
haplotyping.
MATERIALS AND METHODS
DNA preparation
DNA was puriﬁed from blood by conventional isolation
methods such as the Qiagen EZ1 magnetic separation kit
from 350ml of whole blood or ethanol precipitation (25)
from 5–7ml of whole blood.
Genotyping
A segment of DNA within the MHC that includes the
HLA-C, HLA-B and MICA genes was selected to test
whether a combination of SNP-based haploseparation
and downstream characterization can determine extended,
molecular haplotype information across this region. Low-
resolution genotyping of diploid, genomic DNA samples
at HLA-B and HLA-C was determined using Olerup
SSP
TM HLA-A-B-C combi tray (Qiagen, GmbH,
Hilden, Germany) according to manufacturer’s protocol.
High-resolution typing at HLA-C and HLA-B was deter-
mined with Olerup SSP kits (Qiagen). MICA was typed
with sequencing. Each 25ml PCR reaction contained
1  Qiagen PCR buﬀer, 200mM each dNTP, 0.3mM
each forward and reverse primers (26), and 2.5U of Hot
Star polymerase (Qiagen). The PCR thermal cycling con-
ditions began with a 15min denaturation at 958C followed
by 35 cycles of 968C for 30s, 648C for 30s and 728C for
2min with an additional 10min ﬁnal extension at 728C.
PCR products were cleaned prior to sequencing reactions
by adding 4ml ExoSAP-IT (USB) to 10ml PCR products,
incubating at 378C for 45min and inactivating the enzyme
with heat at 808C for 15min. BigDye chemistry was used
for cycle sequencing; however, each 10ml sequencing
reaction included 0.25  BigDye Terminator v1.1 Cycle
Sequencing RR-100 (ABI), 0.75  BigDye buﬀer,
0.16mM primer (26) and 2ml(  100ng) cleaned PCR pro-
ducts. Thermal cycling conditions consisted of a 1min
denaturation at 968C followed by 25 cycles of 968C
for 10s, 508C for 30s and 608C for 2min. The seq-
uencing reactions were cleaned with CleanSEQ beads
(Agencourt, Beverly, MA, USA) according to manu-
facturer’s protocol and capillary electrophoresis was
performed on an ABI 3130 Sequencing System.
Haplotype-specific extraction
SNP specific. Each 30ml extraction contained 300–500ng
genomic DNA, 5mM SNP-speciﬁc oligos, 1  H-Buﬀer,
which contains a polymerase, dNTPs and biotinylated
dNTPs (Qiagen, Cat. # 4340004, 2  initial concentration)
and DNAse free water. All extractions were performed as
separate reactions and placed on an external heat block
with a heated lid (Hybex
TM SciGene, Sunnyvale, CA,
USA) to denature the DNA at 958C for 15min. The sam-
ples were then transferred to a BioRobot EZ1, which
completes a 20min incubation at 648C during which the
allele-speciﬁc oligos anneal and are extended, incorporat-
ing biotinylated dNTPs. The targeted genomic DNA is
captured with streptavidin-coated magnetic microparticles
by continuous relative motion of the beads through
the ﬂuid. The targeted, haploid DNA on the particles is
then washed twice with wash buﬀer by gentle mixing
within the tip. The particles carrying the targeted
DNA are then collected with a magnet and resuspended
in 50ml EB buﬀer by the EZ1. Reagent cartridges, includ-
ing streptavidin-coated magnetic particles and buﬀers, are
commercially available (Qiagen, Cat. # 4340004).
In this experiment, genomic DNA was separated at
a SNP intermediate to HLA-B and HLA-C, rs1634789
(A/G). Each allele was extracted using oligos which selec-
tively target alleles based on a single base diﬀerence.
Positions of oligos are shown in Table 1. DNA was also
separated at a SNP intermediate to HLA-B and MICA,
rs2507984 (A/G). Again, each allele was extracted using
oligos which selectively target alleles based on a single
base change (Table 1).
HLA-allele specific. For each extraction at HLA-C and
HLA-B, genomic DNA was separated as described above
with 1.5ml of commercially available allele-speciﬁc oligos
in 30ml total reaction volume (HaploPrep HLA B539A,
B355A, C102C and C419T; Qiagen).
Table 1. Positions of oligonucleotides and the polymorphisms they
detect
SNP Targeted
polymorphism/position
50 base 30 base
rs1634789
a rs1634789-A/31385066 31385081 31385065
rs1634789-T/31385066 31385044 31385067
rs1634789-G/31385066 31385081 31385065
rs1634789-C/31385066 31385044 31385067
rs2507984 rs2507984-A/31453575 31453592 31453574
rs2507984-G/31453575 31453591 31453574
aForward and reverse oligos were used in combination to extract allele-
speciﬁc DNA at this SNP.
The positions map to NCBI reference assembly build 36.2.
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The isolated haploid DNA bound to the magnetic micro-
particles was directly substituted for diploid DNA in stan-
dard genotyping assays or sequencing reactions. It is
practical and economical to leave the DNA on the parti-
cles; however, at high concentrations the particles may
interfere with subsequent ﬂuorescent detection steps.
When typing with TaqMan assays, the captured DNA
was removed from the particles by incubating the eluted
sample for 10min at 808C (27), removing the magnetic
particles and transferring the captured DNA in solution
to a new tube.
Sequencing. For HLA and MICA sequence-based typing,
haploid DNA was kept associated with the beads. Five
microliters of the haploid DNA from these extractions
were used in all sequencing reactions. HLA-B was
sequenced with commercially available kits (Atria
Genetics, South San Francisco, CA, USA and Genome
Diagnostics, Utrecht, NL, USA) and the number of
cycles in PCR was increased to 45. MICA was sequenced
as described above, increasing the number of PCR cycles
from 35 to 37.
HLA-C was ampliﬁed using PCR primers, 50-AGATG
GGGAAGGCTCCCCACT-30 and 50-CGAGGKGCC
CKCCCGGCGC-30 to delineate exons 2 and 3 of the
gene. Each 25ml PCR reaction contained 1  Qiagen
PCR buﬀer, 2mM MgCl2, 200mM each dNTP, 0.25mM
each primer and 0.75  Q–solution (Qiagen). The PCR
cycles included a 10min denaturation at 958C followed
by 45 cycles of 968C for 20s, 658C for 30s and 728C for
2min with a 4min extension step at 728C. PCR product
cleanup and cycle sequencing was performed as described
above under MICA typing. Sequencing primers 2F (50-GG
AGCCGCGCAGGGAG-30), 2R (50-AGGGGTCGT
GACCTGCG-30), 3F (GGGCTGACCRCGGGGG-30)
and 3R (AAGGCTCCCCACTGCCC-30) were used to
sequence both strands of HLA-C exons 2 and 3. Primers
were from Integrated DNA Technologies Inc., Coralville,
IA, USA. ‘K’ in the nucleotide sequence denotes a ‘G,T’
mixed base position; ‘R’ an ‘A,G’ mixed base position.
Quantitative PCR. The samples were typed at three SNPs,
rs1634789, rs2507984 and rs1131896 using TaqMan real-
time PCR system (ABI 7300, Applied Biosystems). All
TaqMan assays used standard 2  Master Mix (no
AmpErase UNG) and TaqMan probes from ABI.
Reactions were 20ml( 9 ml of DNA sample, 10ml
TaqMan master mix and 1 ml TaqMan probe), and were
run for 40 cycles using absolute quantitation with a seri-
ally diluted diploid standard ranging from  15000 to 50
copies. SNP typing was performed on extracted haploid
DNA removed from the magnetic particles as described
above. Allele typing was determined based on copy
number with the ABI PRISM Sequence Detection
System software package by interpolation to a plot of Ct
values versus the logarithm of copy number of the serially
diluted genomic DNA standard.
RESULTS
Diploid DNA from a four-member family (parent 1,
parent 2 and two siblings) was genotyped at HLA-C,
SNP rs1634789, HLA-B, SNP rs2507984, MICA and
SNP rs1131896 by sequencing and/or TaqMan assays
(Table 2, panel a). All family genotypings were successful
except that of the MICA gene. As shown later (Figure 3),
the diﬃculty was due to a single base diﬀerence within one
of two tandem repeat alleles in the diploid sample, which
resulted in out-of-phase electropherograms. We used a
single sample (parent 1) with heterozygous positions at
these ﬁve loci for long-range molecular haplotyping.
Based on the family’s genotyping, the haplotype for this
sample was derived (Table 2, panel b). The objective was
to determine whether the haplotypes derived molecularly
by haploseparation were equivalent to the known haplo-
types, derived from family genotyping.
Table 2. Family genotype information (panel a), haplotype for parent 1 predicted from familial data (panel b) and molecular haplotype for parent 1
of 146.6kb region (HLA-C to MICA) obtained by haploseparation (panel c)
HLA-C SNP
rs1634789
HLA-B SNP rs2507984 MICA SNP
rs1131896
Panel a
Parent 1 0702/0401 A/G 0801/3501 A/G – A/G
Parent 2 0102/0202 A/A 2705/1501 G/G – A/A
Child 1 0102/0401 A/A 2705/3501 G/G – A/A
Child 2 0102/0401 A/A 2705/3501 G/G – A/A
Panel b
Haplotype 1
(Parent 1)
0401 A 3501 G – A
Haplotype 2
(Parent 1)
0702 G 0801 A – G
Panel c
Haplotype 1
(Parent 1)
0401 A 3501 G 016/A5 A
Haplotype 2
(Parent 1)
0702 G 0801 A 008/A5.1 G
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We designed oligos to target the A (rs1634789-A/T) and G
(rs1634789-G/C) alleles of rs1634789 (Table 1), located
between HLA-Cw and HLA-B, to separate diploid geno-
mic DNA from parent 1 into its haploid components
based on this heterozygous SNP (Figure 2). The extracted
samples were then sequenced at HLA-Cw and HLA-B.
The haploid DNA extracted with the oligo targeting the
G allele typed as Cw 0702 and B 0801, while the DNA
extracted with the oligo that targeted the A allele typed as
Cw 0401 and B 3501. Both sets of experiments conﬁrmed
the known familial haplotype data (Figure 2a and c:
A-allele in yellow, G-allele in blue).
To further conﬁrm the molecular haplotypes derived
from separating the sample at SNP rs1634789, genomic
DNA from parent 1 was haploseparated at HLA-Cw
with oligos C102C and C419T (Qiagen) targeting the
Cw 0702 and Cw 0401 alleles respectively, and at HLA-
B with oligos B539A and B355A (Qiagen) that target the
B 0801 and B 3501, respectively. All four haplosepara-
tions were performed as separate reactions. The haploid
DNA from each reaction was then assayed by quantitative
PCR at SNP rs1634789 (Figure 2b). The haploseparated
DNA which used oligos targeting Cw 0401 and B 3501
resulted in SNP rs1634789 typing as A, while the haplo-
separated DNA which used oligos targeting Cw 0702 and
B 0801 typed this SNP as G conﬁrming the molecular
haplotypes derived from the haplo-separations with
oligos rs1634789-A/T and rs1634789-G/C and assembling
a molecular haplotype across an 85kb region. The haplo-
separated DNA obtained by targeting the HLA-B alleles
in the two separate reactions. These extractions were typed
with quantitative PCR at SNP rs2507984 located between
HLA-B and MICA (20.6kb from HLA-B and 25.7kb
from MICA) (Figure 2d). Both haploseparated samples
ampliﬁed in this assay, linking B 3501 to the G allele
and B 0801 to the A allele of SNP rs2507984. This
extended the assembled haplotype to  106kb.
Oligos rs2507984-G and rs2507984-A (Table 1) were
then used to separate the G and A alleles at SNP
rs2507984. The haploid samples were tested for separation
at the extraction site with a quantitative PCR assay that
targets SNP rs2507984. Having conﬁrmed the haploid
nature of the DNA, the samples were tested at SNP
rs1131896 in exon 3 of MICA and also sequenced at
MICA (Figure 2e). The haploid DNA derived from target-
ing the G allele of rs2507984 typed as A at SNP rs1131896
and sequenced as MICA allele 016/A5, while the DNA
derived from targeting the A allele of rs2507984 typed as
G at SNP rs1131896 and sequenced as MICA allele 008/
A5.1. Data from the SNP typing of rs1131896 by quanti-
tative PCR are not shown in Figure 2. Again, both sets
of experiments conﬁrmed the familial haplotype data.
With this approach it was demonstrated that haploid
DNA can be obtained whether we target HLA or SNP
polymorphisms and that the haplotypes determined by
Figure 2. Molecular haplotype mapping of HLA-C, HLA-B and MICA. Each contiguous haplotype is denoted by color: haplotype 1, yellow;
haplotype 2, blue. Oligos were designed to separate the A and G alleles at SNP rs1634789 for subsequent sequencing at HLA-C (a) and HLA-B (c).
Sequencing electropherograms are shown for both alleles. The alleles Cw 0401 and Cw 0702 were separated at HLA-C and typed at SNP rs1634789
by quantitative PCR (b; y-axis, copy number per ml after extraction). The alleles B 3501 and B 0801 were separated at HLA-B and typed at SNPs
rs1634789 (b) and rs2507984 (d). The A and G alleles at SNP rs2507984 were separated with oligos targeting this SNP and sequenced at HLA-B (c)
and MICA (e).
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tical to those derived from family genotyping (Table 2b);
therefore conﬁrming the utility of the method. The size of
the region that was linked by this molecular haplotyping
approach is 146.6kb.
In a related set of experiments (data not shown), a
sample with unknown HLA-B/MICA typing was haplo-
separated at SNP rs2507984 with oligos rs2507984-G and
rs2507984-A (Table 1). The extracted haploid material
was sequenced at HLA-B and MICA. The sequence-
based typing of the haploid DNA as HLA-B 5001/
MICA 01201/A4 and HLA-B 4002/MICA 027/A5
matched subsequent parental HLA-B/MICA typing, con-
ﬁrming that extended molecular haplotypes can be deter-
mined at two or more separate gene locations with a single
SNP-speciﬁc separation.
Resolution ofshort-tandem repeat (STR) by haploseparation
andsequencing
During the typing of the MICA region, a separate pro-
blem was encountered and resolved: the MICA gene con-
tains an STR element in exon 5, which is particularly
diﬃcult to sequence due to a variable number of GCT
repeats in heterozygous samples. This site is also a key-
diﬀerentiating factor for allelic determination at MICA,
with diﬀerences in the number of repetitive elements as
small as single base changes. Extension products of sam-
ples with diﬀerent numbers of GCT repeats often become
unreadable when the samples are no longer in phase with
each other and must be subsequently resolved by size dif-
ferentiation with fragment analysis. In our experiments,
the initially unreadable sequence of the diploid sample
for parent 1 was fully resolved to 5 and 5.1 repeats after
sequencing SNP extracted haploid DNA (Figure 3).
Assay performance overdistance
In the ﬁrst part of the results, we demonstrated our strat-
egy and the performance of the method for targeting par-
ticular haplotypes, characterization by TaqMan assays or
DNA sequencing and tiling to generate extended haplo-
types. Here, we present documentation of the perfor-
mance, reproducibility and limits of this technology in
its current stage.
A total of 371 TaqMan assays were performed on 244
haplospeciﬁc extractions using eight diﬀerent genomic
DNA samples as input. The genomic DNA for these
experiments was routinely extracted by standard protocols
described in the Materials and methods section. Eighty-
ﬁve of the haplospeciﬁc extractions targeted 15 SNP poly-
morphisms, while the other 159 extractions targeted 14
polymorphic sites within the HLA-B, -C genes and seven
polymorphic sites within MICA.
Of the 85 haplospeciﬁc extractions that targeted SNP
polymorphisms, 76 (89%) were considered successful as
they provided DNA that was at least 100% enriched for
the targeted allele, thereby allowing successful determina-
tion of haplotypes by TaqMan assays. Although there is
some ﬂuctuation in the percentage of successful haplose-
parations (59–100%), the ratio of targeted to nontargeted
allelic forms is high (110 and 270) within 5kb of the
extraction point and decreases to about 30 between 10
and 30kb (Table 3). When the distance from the capture
point is over 30kb and up to 43kb, a gradual drop of both
the percentage of successful haploseparations and of the
ratio of targeted versus nontargeted regions is observed.
This eﬀect is to be expected based on the average size
distribution of the available DNA fragments containing
the targeted locus: a larger number of copies from various
captured DNA fragments are available near the targeted
Figure 3. A region located in exon 5 of the MICA gene contains STRs, which often resist sequence-based typing of heterozygous samples due to out-
of-phase extension products. When a separation of the alleles is carried out before sequencing, the typing of the sample becomes possible. Sequencing
electropherograms are shown for forward (upper panels) and reverse orientation (lower panels).
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as template. As the distance from this point increases, a
reduction of targeted copies is observed. The total size of
the region characterized around the capture point is often
larger than the individual DNA fragments captured and
depends on whether a suﬃcient number of captured frag-
ments contain ﬂanking sequences which extend in either
direction. This is conﬁrmed by the ability to characterize
DNA after haplopreparation up to at least 42kb to either
side of the capture point. However, the TaqMan assays
performed at these distances tend to be less robust and
show reduced enrichment due to the decreased number of
template available.
DISCUSSION
The selective targeting of unique genomic variations and
the isolation of large fragments of haploid DNA provide a
valuable tool for addressing a number of current pro-
blems, including, but not limited to the characterization
of particular genomic segments pointed to by genome-
wide association SNP analysis studies, the evaluation of
regions with variable copy numbers and the generation of
molecular haplotypes when familial or computational
approaches are limiting or not possible. The method pre-
sented here is a simple, robust tool for extracting large
genomic regions including their surrounding sequence
context (22–24). By selectively targeting unique genomic
variation, including SNPs, individual molecular haplo-
types can be isolated and characterized. This method has
been used extensively to resolve short-range HLA allele
ambiguities and determine new HLA alleles (25,29,30).
Here, a segment of about 150kb within the MHC that
includes HLA-C, HLA-B and MICA was characterized,
demonstrating the ability of this method for SNP-speciﬁc
targeting of genomic regions from individual samples by
an automated method, which can generate phased
sequences by DNA sequencing or TaqMan assays. The
information is assembled based on the overlap of multiple
haploid DNA fragments at shared heterozygous positions.
Complex and potentially unknown genotyping problems
may be resolved, such as the one encountered while typing
the MICA gene (described in Results section). Sequencing
failures caused by frame shifting are avoided by the
separation of repetitive elements into their respective
alleles (Table 2, panel c and Figure 3).
The performance of SNP-speciﬁc extractions is inﬂu-
enced by the selection of the targeting oligos and it is
useful to evaluate multiple oligos to determine, which
best increases the enrichment level of the targeted allele.
Any single polymorphic site is typically placed at the 30-
end n 1 position of the oligo. If multiple polymorphic
sites are available, these positions are all placed towards
the 30-end of the oligo. Certain types of base mismatches
and combinations of mismatch and preceding sequence
are exploited where possible due to their greater ability
to disrupt enzymatic extension (31). Any given SNP can
be separated by four diﬀerent types of oligos, with each
one targeting one of the two possible alleles on either the
forward or reverse strand.
Example: for an A/G SNP, forward-oriented oligos can
bedesignedthatperfectlymatcheitherthe‘T’or‘C’present
on the respective reverse strand of the genomic template,
and reverse-oriented oligos can be designed to match the
‘A’ or ‘G’ present on the forward strand of the genomic
template. It is also possible to combine both forward- and
reverse-oriented oligos that target the same allele, but we
have not seen any consistent diﬀerence in overall perfor-
mance compared to the use of single oligos. Generally, our
experience is that of the 32 oligos we have designed for
targeting SNPs, 27 (84%) performed well, providing allelic
discrimination. Our current practice is to synthesize four
diﬀerentoligosforeverySNP,totargeteachoftheallelesin
the forward and reverse direction. These are evaluated by
quantitative PCR at the extraction site and the best perfor-
mers are selected for future extractions.
The length of haploseparated DNA fragments depends
primarily on the size of the diploid input DNA, i.e. on the
genomic DNA extraction method used. Automated and
commercially available DNA preparation methods consis-
tently provide diploid DNA fragments with an average size
limit of about 40kb. The ability to characterize in forward
and reverse directions from the extraction point is based on
the capture of the original genomic template itself, along
with the enzymatically extended portion of the targeting
oligo. The enzymatically extended portion is simply an
anchor point for capturing the haploid DNA. The condi-
tional, SNP-speciﬁc extension of a perfectly matched oligo
with multiple biotins topologically locks large genomic
fragments to the bead surface for extraction.
Given the fact that heterozygous SNPs in a typical
sample occur with an average of about 18kb (32,33), and
since DNA can routinely be haploseparated at these dis-
tances from the capture point, this means that extended
haplotypes can reliably be derived for individual samples
Table 3. Number of TaqMan assays performed at diﬀerent distances
from the point of haplospeciﬁc extraction, percent of successful extrac-
tions (A successful extraction is deﬁned as providing at least 100%
increase in TaqMan copy number of the targeted allele over the copy
number of the non-targeted allele) and average of enrichment ratios
(deﬁned as copy number of the targeted allele per one copy of the
non-targeted allele)
Distance to
target (kb)
n Percent
success (%)
Average
(target/non-target ratio)
0 76 88 110
5 18 100 270
11.6 4 100 29
12.5 61 98 50
20.5 31 74 29
21.3 18 100 10
27.8 14 86 6.7
28.3 16 81 4.7
31.6 15 100 20
32.4 2 100 30
37.8 16 75 9.4
42.2 22 64 4.8
42.4 18 83 2.7
42.7 34 59 2.8
47.2 26 88 4.0
Total 371 86
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overall linkage distance that can be achieved with this
approach is therefore independent of the DNA fragment
length that is available for any given region. Haplotype
blocks in the human genome rarely exceed 100kb (34)
and therefore this method is an appropriate step to char-
acterize such regions after they have been identiﬁed in an
association study.
Even though this method thus far has primarily been
used for targeting genomic regions within the MHC, it can
easily be extended to other regions. Also, its potential to
generate short-range haplotype information has been con-
ﬁrmed and utilized successfully for characterizing new
HLA alleles and resolve HLA typing ambiguities
(22,24,25,29,30). We demonstrate that by haploseparating
and tiling neighboring regions we can generate phased
sequence information of almost 150kb. Overlapping hap-
loid segments can in principle be joined together to derive
extended haplotypes over arbitrary distances.
Obtaining long-range, molecular haplotype information
for numerous individuals will improve disease association
studies and aid in better characterizing the genetics of
complex disease. Statistical approaches do not always pre-
sent a full alternative because they are not able to derive
with certainty molecular linkage information for indivi-
dual samples. SNP-speciﬁc extracted DNA overcomes
limitations in current technologies by its near universal
compatibility with common genotyping systems and pro-
vides an eﬃcient method of examining potentially rare
haplotype signatures for preexisting, individual samples.
The ability to reduce genomic complexity by selectively
isolating speciﬁc regions from a given sample and deter-
mine molecular linkage across broad genomic regions in a
high-throughput format could also be a useful tool to help
deconvolute copy number and structural genomic varia-
tion in next-generation sequencing applications.
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